Acute myocardial infarction induced by avatrombopag: a case report

Acute myocardial infarction induced by avatrombopag: a case report

BackgroundAvatrombopag, a thrombopoietin receptor agonist (TPO-RA), is used for immune thrombocytopenia (ITP) but confers thrombotic risks. Acute myocardial infarction (AMI) as an adverse event is underreported.SummaryA 58-year-old female with steroid-refractory ITP developed ST-elevation myocardial...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gou Junqi, Liu Chaohui, Lang Miangjian, Yao Fengyou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Pharmacology
Subjects:	avatrombopag acute myocardial infarction coronary thrombosis immune thrombocytopenia thrombopoietin receptor agonists
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1618693/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

Case Report: A case of pediatric persistent refractory ITP responsive to avatrombopag
by: Antonella Sau, et al.
Published: (2025-04-01)

A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists
by: Mohamed A. Yassin, et al.
Published: (2025-02-01)

Literature Review and Experts’ Opinion for Managing Thrombocytopenia in Chronic Liver Disease
by: Faisal Alsayegh, et al.
Published: (2025-01-01)

Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01)

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?
by: Hanny Al-Samkari
Published: (2025-07-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01)

Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
by: Davide Scalabrini, et al.
Published: (2023-08-01)

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01)

Glucocorticosteroid-induced complications in patients with idiopathic thrombocytopenic purpura
by: S. G. Zakharov, et al.
Published: (2023-12-01)

Investigation of the <i>ABCB1</i> Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic Analysis
by: Xin Liu, et al.
Published: (2025-06-01)

A case with a novel GATA1 variant mimicking immune thrombocytopenia attacks
by: Elif Habibe Aktekin, et al.
Published: (2025-12-01)

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments
by: Andrea Aiello, et al.
Published: (2023-12-01)

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK
by: Nichola Cooper, et al.
Published: (2025-03-01)

A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
by: Zhong Xue, et al.
Published: (2024-11-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Research progress in the treatment of chronic primary immune thrombocytopenia
by: HUANG Zhouxuan, et al.
Published: (2025-04-01)

Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China
by: Lingling Fu, et al.
Published: (2025-02-01)

Effect of the anxiolytic fabomotizol on the time parameters of atrial depolarization in the acute phase of myocardial infarction
by: S. L. Smirnova, et al.
Published: (2023-01-01)

Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports
by: Waleed Ghanima, et al.
Published: (2025-12-01)

Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature
by: Roberto Castelli, et al.
Published: (2025-02-01)

Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain
by: Eduardo Anguita, et al.
Published: (2020-11-01)

Targeting Inflammation and Immune System in Acute Myocardial Infarction
by: Idrus Alwi
Published: (2020-02-01)

Targeting Inflammation and Immune System in Acute Myocardial Infarction
by: Idrus Alwi
Published: (2020-02-01)

Comparison of outcomes of coronary artery stenting in acute myocardial infarction due to massive coronary thrombosis
by: A. V. Azarov, et al.
Published: (2023-12-01)

Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease
by: Yuuka Shibata, et al.
Published: (2025-08-01)

Splenic Infarction and Myocardial Infarction in A Patient with COVID-19 on Anticoagulant Therapy with Normal D-Dimer Levels
by: M. I. Grusha, et al.
Published: (2024-01-01)

Ventricular septal rupture after acute myocardial infarction in a patient with venous thromboembolism complicated by thrombocytopenia: A case report
by: Yuansong Zhu, et al.
Published: (2023-03-01)

Case Report: Anaphylactic shock and ST-elevation myocardial infarction following a bee sting: two deadly diseases in a patient with Kounis syndrome
by: Guido Del Monaco, et al.
Published: (2025-05-01)

IMMUNOMARKERS IN ACUTE CORONARY SYNDROME UPON ADMISSION AND ITS TRANSITION TO MYOCARDIAL INFARCTION
by: Marzhanat G. Alieva
Published: (2017-12-01)

Real-world experience of hetrombopag in immune thrombocytopenia treatment: a retrospective cohort study
by: Dan Wang, et al.
Published: (2025-07-01)

Myocardial infarction with nonobstructive coronary arteries (MINOCA): a narrative review
by: Pengfei Yang, et al.
Published: (2025-06-01)

Clinical Characteristics and Outcome of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries in Japan: Insights From the Miyagi Acute Myocardial Infarction Registry Study
by: Kiyotaka Hao, et al.
Published: (2025-03-01)

EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01)

Treatment of patients with refractory immune thrombocytopenia: literature review and case report
by: V. V. Ptushkin, et al.
Published: (2014-07-01)

Short-term recurrent coronary artery thrombosis with acute myocardial infarction in a patient with aplastic anemia–paroxysmal nocturnal hemoglobinuria syndrome: a case report
by: Xue-Guo Fu, et al.
Published: (2025-03-01)

Raising Awareness of ST-Segment Elevation Myocardial Infarction Triggered by Intravenous Regadenoson for Cardiac Stress Testing
by: Ruihai Zhou, MSc, MD
Published: (2025-07-01)

Cardiometabolic Modulation by Semaglutide Contributes to Cardioprotection in Rats with Myocardial Infarction
by: Yan H, et al.
Published: (2024-11-01)

ATYPICAL CLINICAL COURSE OF THE ACUTE MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTIC OF PATIENTS, MANAGEMENT AND OUTCOMES (DATA FROM REGISTRY OF ACUTE MYOCARDIAL INFARCTION)
by: A. А. Garganeeva, et al.
Published: (2016-08-01)